First Time Loading...

Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 569 JPY -1.81% Market Closed
Updated: May 21, 2024

Santen Pharmaceutical Co Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santen Pharmaceutical Co Ltd
Pre-Tax Income Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Santen Pharmaceutical Co Ltd
TSE:4536
Pre-Tax Income
¥29.9B
CAGR 3-Years
37%
CAGR 5-Years
-7%
CAGR 10-Years
0%
Takeda Pharmaceutical Co Ltd
TSE:4502
Pre-Tax Income
¥52.8B
CAGR 3-Years
-48%
CAGR 5-Years
-16%
CAGR 10-Years
-10%
Daiichi Sankyo Co Ltd
TSE:4568
Pre-Tax Income
¥237.2B
CAGR 3-Years
47%
CAGR 5-Years
23%
CAGR 10-Years
8%
Otsuka Holdings Co Ltd
TSE:4578
Pre-Tax Income
¥163.5B
CAGR 3-Years
-6%
CAGR 5-Years
8%
CAGR 10-Years
-2%
Chugai Pharmaceutical Co Ltd
TSE:4519
Pre-Tax Income
¥444B
CAGR 3-Years
15%
CAGR 5-Years
28%
CAGR 10-Years
17%
Astellas Pharma Inc
TSE:4503
Pre-Tax Income
¥25B
CAGR 3-Years
-44%
CAGR 5-Years
-37%
CAGR 10-Years
-15%

See Also

What is Santen Pharmaceutical Co Ltd's Pre-Tax Income?
Pre-Tax Income
29.9B JPY

Based on the financial report for Mar 31, 2024, Santen Pharmaceutical Co Ltd's Pre-Tax Income amounts to 29.9B JPY.

What is Santen Pharmaceutical Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
0%

The average annual Pre-Tax Income growth rates for Santen Pharmaceutical Co Ltd have been 37% over the past three years , -7% over the past five years .